HPTN Publications

Brewer RA, Magnus M, Kuo I, Wang L, Liu TY, Mayer KH . The high prevalence of incarceration history among black men who have sex with men in the United States: associations and implications. Am J Public Health. 2014, 104: 448-54

Broder GB, Lucas JP, Davis J, Wallace SE, Luthuli N, Baepanye K, White RR, Bolton M, Blanchette C, Andrasik M . Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials. PLoS One. 2020, 15: e0239276

Brogan AJ, Davis AE, Mellott CE, Fraysse J, Metzner AA, Oglesby AK . Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. Pharmacoeconomics. 2024, 42: 447-461

Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH . Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol. 2013, 177: 264-72

Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH . Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr. 2013, 63: S233-9

Brown E, Chi BH, Read JS, Taha T, Sharma U, Hoffman IF, Pikora C, Goldenberg RL, Fiscus S . Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period. AIDS. 2008, 22: 2341-6

Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C . High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006, 164: 733-41 PMID 16896053

Brown TT, Yuhas K, Mayer KH, Landovitz RJ, Marzinke MA, Hendrix CW, Chen YQ, Klingman KL, Chege W, Mccauley MB, Gulick RM, Wilkin TJ . Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305. J Antimicrob Chemother. 2022, 77: 500-506